Literature DB >> 20573027

Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology.

Shuji Izumo1.   

Abstract

A series of our neuropathological studies was reviewed in order to clarify pathogenesis of human T lymphotropic virus type 1(HTLV-1)-associated myelopathy (HAM)/tropical spastic paraparesis (TSP). The essential histopathologic finding was chronic inflammation in which inflammatory infiltrates of mononuclear cells and degeneration of myelin and axons were noted in the entire spinal cord. Immunohistochemical analysis demonstrated T-cell dominance, and the numbers of CD4+ cells and CD8+ cells were equally present in patients with shorter clinical courses. Apoptosis of helper/inducer T-cells were observed in these active inflammatory lesions. Horizontal distribution of inflammatory lesions was symmetric at all spinal levels and was accentuated at sites with slow blood flow in the middle to lower thoracic levels. HTLV-1 proviral DNA amounts were well correlated with the numbers of infiltrated CD4+ cells. In situ PCR of HTLV-1 proviral DNA and in situ hybridization of HTLV-1 Tax gene demonstrated the presence of HTLV-1-infected cells exclusively in the mononuclear infiltrates of perivascular areas. From these findings, it is suggested that T-cell mediated chronic inflammatory processes targeting the HTLV-1 infected T-cells is the primary pathogenic mechanism of HAM/TSP. Anatomically determined hemodynamic conditions may contribute to the localization of infected T-cells and the formation of main lesions in the middle to lower thoracic spinal cord.
© 2010 Japanese Society of Neuropathology.

Entities:  

Keywords:  HAM/TSP; HTLV-1; immunohistochemistry; in situ PCR; pathogenesis

Mesh:

Substances:

Year:  2010        PMID: 20573027     DOI: 10.1111/j.1440-1789.2010.01135.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  23 in total

1.  Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.

Authors:  Monique R Anderson; Yoshimi Enose-Akahata; Raya Massoud; Nyater Ngouth; Yuetsu Tanaka; Unsong Oh; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-21       Impact factor: 4.147

2.  Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?

Authors:  Marina Lobato Martins; Jacqueline Cronemberger Guimarães; João Gabriel Ribas; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti
Journal:  J Neurovirol       Date:  2016-09-27       Impact factor: 2.643

3.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

4.  Myelopathy secondary to human T-lymphotropic virus and Treponema pallidum infection: case report.

Authors:  Pilar Enríquez-Ruano; Cristian Eduardo Navarro; Michael Ariza-Varón; Andrea Del Pilar Calderón-Castro
Journal:  Spinal Cord Ser Cases       Date:  2019-11-06

5.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

6.  Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Luciana Cristina Matos Cunha; Maurício Campelo Tavares; Carlos Julio Tierra Criollo; Ludimila Labanca; Clarissa Cardoso Dos Santos Couto Paz; Henrique Resende Martins; Anna Bárbara de Freitas Carneiro-Proietti; Denise Utsch Goncalves
Journal:  J Clin Neurol       Date:  2013-10-31       Impact factor: 3.077

7.  Hypometabolism of watershed areas of the brain in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Akitoshi Taniguchi; Hitoshi Mochizuki; Shigeki Nagamachi; Yuka Ebihara; Nobuyuki Ishii; Kazutaka Shiomi; Masamitsu Nakazato
Journal:  Neurol Sci       Date:  2015-07-09       Impact factor: 3.307

8.  CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.

Authors:  Nicolas Barros; Jorge Risco; Carlos Rodríguez; Cesar Sánchez; Elsa González; Yuetsu Tanaka; Eduardo Gotuzzo; A Clinton White; Martin Montes
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

9.  HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.

Authors:  Marina Lobato Martins; Anna Bárbara de Freitas Carneiro-Proietti; Rodrigo Nicolato; Débora Marques de Miranda; Luiz Cláudio Ferreira Romanelli
Journal:  J Neurovirol       Date:  2018-03-27       Impact factor: 2.643

10.  Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.

Authors:  Taraneh Rajaei; Hamid Farajifard; Seyed Abdolrahim Rezaee; Mahmoud Reza Azarpazhooh; Mahmoud Mahmoudi; Narges Valizadeh; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2018-10-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.